KACD
Articles
- Page Path
- HOME > Restor Dent Endod > Volume 45(1); 2020 > Article
- Research Article Cytocompatibility and cell proliferation evaluation of calcium phosphate-based root canal sealers
-
Letícia Boldrin Mestieri1
, Ivana Maria Zaccara1, Lucas Siqueira Pinheiro1, Fernando Branco Barletta2, Patrícia Maria Polli Kopper1, Fabiana Soares Grecca1 -
DOI: https://doi.org/10.5395/rde.2020.45.e2
Published online: November 15, 2019
1Departament of Conservative Dentistry, School of Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
2School of Dentistry, Lutheran University of Brazil - ULBRA, Porto Alegre, RS, Brazil.
- Correspondence to Lucas Siqueira Pinheiro, DDS, MSc. PhD Student, Department of Conservative Dentistry, School of Dentistry, Federal University of Rio Grande do Sul, Av. Ramiro Barcelos, 2492, Porto Alegre, RS 90035-003, Brazil. lucaspinheiroodonto@gmail.com
• Received: July 18, 2019 • Revised: September 24, 2019 • Accepted: October 17, 2019
Copyright © 2020. The Korean Academy of Conservative Dentistry
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 23 Views
- 0 Download
Abstract
-
Objectives This study aimed to evaluate the cell viability and migration of Endosequence Bioceramic Root Canal Sealer (BC Sealer) compared to MTA Fillapex and AH Plus.
-
Materials and Methods BC Sealer, MTA Fillapex, and AH Plus were placed in contact with culture medium to obtain sealers extracts in dilution 1:1, 1:2 and 1:4. 3T3 cells were plated and exposed to the extracts. Cell viability and migration were assessed by 3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide (MTT) and Scratch assay, respectively. Data were analyzed by Kruskal-Wallis and Dunn's test (p < 0.05).
-
Results The MTT assay revealed greater cytotoxicity for AH Plus and MTA Fillapex at 1:1 dilution when compared to control (p < 0.05). At 1:2 and 1:4 dilutions, all sealers were similar to control (p > 0.05) and MTA Fillapex was more cytotoxic than BC Sealer (p < 0.05). Scratch assay demonstrated the continuous closure of the wound according to time. At 30 hours, the control group presented closure of the wound (p < 0.05). At 36 hours, only BC Sealer presented the closure when compared to AH Plus and MTA Fillapex (p < 0.05). At 42 hours, AH Plus and MTA Fillapex showed a wound healing (p > 0.05).
-
Conclusions All tested sealers demonstrated cell viability highlighting BC Sealer, which showed increased cell migration capacity suggesting that this sealer may achieve better tissue repair when compared to other tested sealers.
INTRODUCTION
Calcium silicate sealers have been developed aiming to find a material that has excellent biological properties and to associate different components that may improve the physical-chemical and mechanical properties. When in contact with tissue fluids, they produce calcium hydroxide ions, which are essential for the formation of hydroxyapatite [1,2], and have been termed bioactive endodontic materials [3]. However, the cytotoxicity of these sealers may cause cellular degeneration and delayed wound healing because of the direct contact of materials with periapical tissues.
MTA Fillapex (Angelus S/A, Londrina, PR, Brazil) is composed of salicylate resin, resin diluent, natural resin, bismuth oxide, silica nanoparticles, and calcium silicate. It was created combining a material with excellent biocompatibility and bioactive potential such as MTA with synthetic resins with good physical properties. However, this blend has shown cytotoxicity [4,5]. The Brasseler Industry (Savannah, GA, USA) introduced the EndoSequence Root Repair Material; a premixed bioceramic material indicates to pulp capping/pulpotomy, perforation repair, apexification, and root-end filling. This material promoted cell migration and survival of human bone marrow-derived mesenchymal cells, periodontal ligament cells, and dental pulp stem cells [6]. As a root canal sealer, the EndoSequence Bioceramic Root Canal Sealer (BC Sealer, Brasseler) is a bioceramic-based material composed of tricalcium silicate, dicalcium silicate, calcium phosphates, colloidal silica, and calcium hydroxide; and uses zirconium oxide as the radiopacifier agent. It also contains water-free thickening vehicles, which enables the sealer to be presented as a premixed paste, facilitating its usage [7,8].
Several methodologies have been proposed for evaluating the cytocompatibility of endodontic sealers, 3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide (MTT) and Scratch assay are widely used methods for this purpose. MTT evaluates the enzymes mitochondrial succinate dehydrogenase, one of the enzymes responsible for cellular respiration, and has become the standard test for assessing cell viability [4,5,6]. For cell migration, the scratch assay mimics the extent of migration of cells in vivo during wound healing. In this assay, the rate of cell migration can be determined by creating an artificial gap on a confluent cell monolayer and, then, to observe cell migration until the gap is closed [9]. Thus, this study aimed to evaluate the viability and migration of 3T3 fibroblast cells when in contact with BC Sealer and compare it with AH Plus and MTA Fillapex sealers.
MATERIALS AND METHODS
BC Sealer, MTA Fillapex, and AH Plus were prepared according to manufactures' instructions. Each material was distributed to wells of two 12-well plates (314.0 mm2 area and 3.0 mm height, n = 8 wells per sealer) (TPP Techno Plastic Products, Trasadingen, Switzerland) before setting. Extracts were obtained by filling of the well with Dulbecco's Modified Eagle medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS; Gibco Life Technologies, Grand Island, NY, USA) and 1% penicillin and streptomycin (P/S; Gibco Life Technologies). The plate with the fresh extract was incubated at 37°C with 100% humidity for 24 hours. Extraction media were collected and passed through a 0.22-mm filter (Merck Millipore, Billerica, MA, USA). Thereafter, 1% of diluted extraction media were prepared with fresh DMEM.
3T3 fibroblasts (ATCC CRL-1658; American Type Culture Collection, Manassas, VA, USA) were cultured at 37°C with 100% humidity and maintained in DMEM supplemented with 10% FBS and 1% P/S. At 80% confluence, the cells were treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich) in the well plates (TPP Techno Plastic Products). Cells were seeded into 96-well plates at a concentration of 1 × 104 cells/well. After 24 hours, the culture medium was removed, and the cells were incubated in the extracts for 24 hours at 37°C in 100% humidity and 5% CO2. DMEM was used as the control.
Cell metabolism was determined by MTT assay, 6 hours, and 24 hours after the exposure of the cells. The 10 µL per well of a 5 mg/mL MTT solution (Sigma-Aldrich) was added in each well, followed by incubation for 3 hours at 37°C, 95% humidity and 5% CO2. After that, the contents of the wells were removed and the colorimetric product solubilized in 100 µL of 0.04 N acidified isopropanol (Sigma-Aldrich). The optical densities of the solutions were measured in a spectrophotometer (Thermo Scientific Multiskan G0; Thermo Fischer Scientific Inc., Waltham, MA, USA) at 570 nm wavelength. The absorbance readouts were normalized with the absorbance of the group of cells exposed to DMEM (control group) and represented the activity of the viable cells. Results were expressed according to the control group (100% viability rate).
Cell migration was evaluated by scratch assay. In order to obtain 90% confluence, 1 × 106 cells per well were plated. After 24 hours of incubation at 37°C, 95% humidity and 5% CO2, using a pipette tip (TPP Techno Plastic Products), 2 defects were done in the cell monolayer, perpendicular to each other. The culture medium was replaced with DMEM containing extracts after 24 hours of the set at the dilution 1:8, defined by a pilot study. Using the Axio Observer Z1 microscope (Zeiss, Göttingen, Germany) coupled to a camera (Axiocammrn, Zeiss) with a 10× magnifying lens (Ecplan-NEOFLUAR 10×/0.3 aperture, Zeiss), After preparation of wound, and every 6 hours, images were taken in 4 different locations of the defects, until the full closure of the wound. The analysis was performed by measuring the areas obtained using Image J software (National Institutes of Health, Bethesda, MD, USA, http://rsbweb.nih.gov/ij/).
Both MTT and Scratch assays were performed in triplicate and repeated 2 independent times. The results were statistically analyzed using Kruskal-Wallis and Dunn's tests, with 5% significance level, with the software program GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
The MTT assay revealed greater cytotoxicity for AH Plus and MTA Fillapex at 1:1 dilution when compared to control (p < 0.05). At 1:2 and 1:4 dilutions, all sealers were similar to control (p > 0.05) and MTA Fillapex was more cytotoxic than BC Sealer (p < 0.05) (Figure 1).
Figure 1
Cell viability results (%) by 3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide (MTT) assay in 3T3 cells exposed to 24 hours for AH Plus, MTA Fillapex and BC Sealer, at dilution of 1:1, 1:2 and 1:4, according to the control group (100% viability rate). Bars with different letters represent significant differences among groups in each dilution extract (p < 0.05).
Scratch assay demonstrated the continuous closure of the wound according to time. At 30 hours, the control group presented closure of the wound (p < 0.05). At 36 hours, only BC Sealer presented the closure when compared to AH Plus and MTA Fillapex (p < 0.05). At 42 hours, AH Plus and MTA Fillapex showed a wound healing (p > 0.05) (Figures 2 and 3).
Figure 2
Cell migration results by scratch assay in 3T3 cells exposed to set extracts of AH Plus, MTA Fillapex and BC Sealer at dilution of 1:8. Percentage of open area by scratch assay in 3T3 cells. Columns with different letters represent significant differences between groups in each evaluated period.
DISCUSSION
Studies suggest that overfilling is associated with unfavorable outcomes [10,11]. Although endodontic sealer reabsorption occurs in many cases, this process is immune driven and thus suggests an inflammatory reaction. Sealer extrusion may occur unintentionally; therefore, the clinicians should select materials that have adequate physical-chemical and biological characteristics [12].
Several methodologies have been used to evaluate the biocompatibility of endodontic sealers, including implantation into living tissues in animals and in vitro tests with different cell lines [4,5,12,13,14,15,16]. In this study, the 3T3 fibroblast cell line was chosen to perform the assays. Fibroblasts are the major constituents of connective tissue and the predominant cell type of the periodontal ligament that will be in contact with endodontic sealers [9].
At 1:1 dilution, AH Plus, and MTA Fillapex presented greater cytotoxicity when compared to control, and BC Sealer was similar to control. At 1:2 and 1:4 dilutions, MTA Fillapex was more cytotoxic than BC Sealer. As well as in a previous cell culture studies [4,5,13,14], MTA Fillapex has presented higher cytotoxicity, despite presenting calcium silicate.
Bioceramic sealers can produce an alkaline pH after mixing, due to the presence of calcium hydroxide on its composition, calcium release is important for the bioactivity of this sealer class [1,17], however, it might negatively influence cell's metabolism, decreasing the viability rate [18], However, the results of this study showed that besides these effects, BC Sealer showed a higher viability. As sealers might inadvertently extrude through the apical constriction during placement [19], the presence of BC Sealer in the apical tissues would promote less cytotoxicity than the other sealers.
The analysis of different cell parameters to evaluate the potential toxicity of the materials is necessary [20]. The scratch assay was first described by Liang et al. [9], reporting that it could mimic the extent of migration of cells in vivo during wound healing. The findings of this assay demonstrated that the closure of the wound occurred for all sealers, being more time consuming for AH Plus and MTA Fillapex. AH Plus and MTA Fillapex present resin in its composition, which can negatively influence the results [21], as also seen in the viability results. Mahdi et al. [22] suppose that MTA Fillapex's genotoxic effect might be associated with the release of the resinous components. On the other hand, the reparative and bioactive capacity of MTA-based materials, such as BC Sealer, was demonstrated when evaluated in connective tissue and osteoblastic cell line of rats [12,16] corroborating the results of this study. This ability may be explained by the presence of particles in their formulation responsible for maintaining a highly alkaline pH around 9, similar to MTA powder [23].
As ISO 10993-514 [24] accepts as cytocompatible sealers, materials that have viability values superior to 70%, it is possible to affirm that the tested materials provided positive results, emphasizing BC Sealer that presented a greater percentage of cellular viability and wound closure faster than the other sealers tested.
CONCLUSIONS
Considering the limits of the methods used herein, it can be concluded that the sealers have cytocompatibility, highlighting BC Sealer which showed increased cell migration capacity. These results may suggest that BC Sealer may achieve better tissue healing when compared to MTA Fillapex and AH Plus. However, further in vitro and in vivo studies are required to confirm the suitability of BC Sealer for clinical application.
-
Conflict of Interest: No potential conflict of interest relevant to this article was reported.
-
Author Contributions:
Conceptualization: Mestieri LB, Zaccara IM.
Data curation: Mestieri LB, Zaccara IM.
Formal analysis: Mestieri LB, Zaccara IM, Pinheiro LS.
Funding acquisition: Barletta FB, Kopper PMP, Grecca FS.
Investigation: Mestieri LB, Zaccara IM.
Methodology: Mestieri LB, Zaccara IM.
Project administration: Barletta FB, Kopper PMP, Grecca FS.
Resources: Barletta FB, Kopper PMP, Grecca FS.
Software: Mestieri LB, Zaccara IM.
Supervision: Barletta FB, Kopper PMP, Grecca FS.
Validation: Barletta FB, Kopper PMP, Grecca FS.
Visualization: Barletta FB, Kopper PMP, Grecca FS.
Writing - original draft: Mestieri LB, Zaccara IM, Pinheiro LS, Barletta FB, Grecca FS.
Writing - review & editing: Pinheiro LS, Grecca FS.
ARTICLE INFORMATION
- 1. Sarkar NK, Caicedo R, Ritwik P, Moiseyeva R, Kawashima I. Physicochemical basis of the biologic properties of mineral trioxide aggregate. J Endod 2005;31:97-100. ArticlePubMed
- 2. Ranjkesh B, Chevallier J, Salehi H, Cuisinier F, Isidor F, Løvschall H. Apatite precipitation on a novel fast-setting calcium silicate cement containing fluoride. Acta Biomater Odontol Scand 2016;2:68-78. ArticlePubMedPMCPDF
- 3. Parirokh M, Torabinejad M, Dummer PM. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part I: vital pulp therapy. Int Endod J 2018;51:177-205. ArticlePubMedPDF
- 4. Silva EJ, Carvalho NK, Ronconi CT, De-Deus G, Zuolo ML, Zaia AA. Cytotoxicity profile of endodontic sealers provided by 3D cell culture experimental model. Braz Dent J 2016;27:652-656. ArticlePubMed
- 5. Rodríguez-Lozano FJ, García-Bernal D, Oñate-Sánchez RE, Ortolani-Seltenerich PS, Forner L, Moraleda JM. Evaluation of cytocompatibility of calcium silicate-based endodontic sealers and their effects on the biological responses of mesenchymal dental stem cells. Int Endod J 2017;50:67-76. ArticlePubMedPDF
- 6. Chen I, Salhab I, Setzer FC, Kim S, Nah HD. A new calcium silicate–based bioceramic material promotes human osteo and odontogenic stem cell proliferation and survival via the extracellular signal-regulated kinase signaling pathway. J Endod 2016;42:480-486. PubMed
- 7. Yang Q, Lu D. Premix biological hydraulic cement paste composition and using the same. United States Patent Application 2008029909. 2008 12 04.
- 8. Loushine BA, Bryan TE, Looney SW, Gillen BM, Loushine RJ, Weller RN, Pashley DH, Tay FR. Setting properties and cytotoxicity evaluation of a premixed bioceramic root canal sealer. J Endod 2011;37:673-677. ArticlePubMed
- 9. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro . Nat Protoc 2007;2:329-333. ArticlePubMedPDF
- 10. Sjögren U, Hagglund B, Sundqvist G, Wing K. Factors affecting the long-term results of endodontic treatment. J Endod 1990;16:498-504. ArticlePubMed
- 11. Schaeffer MA, White RR, Walton RE. Determining the optimal obturation length: a meta-analysis of literature. J Endod 2005;31:271-274. PubMed
- 12. Giacomino CM, Wealleans JA, Kuhn N, Diogenes A. Comparative biocompatibility and osteogenic potential of two bioceramic sealers. J Endod 2019;45:51-56. ArticlePubMed
- 13. Victoria-Escandell A, Ibañez-Cabellos JS, de Cutanda SB, Berenguer-Pascual E, Beltrán-García J, García-López E, Pallardó FV, García-Giménez JL, Pallarés-Sabater A, Zarzosa-López I, Monterde M. Cellular responses in human dental pulp stem cells treated with three endodontic materials. Stem Cells Int 2017;2017:8920356. ArticlePubMedPMCPDF
- 14. Collado-González M, Tomás-Catalá CJ, Oñate-Sánchez RE, Moraleda JM, Rodríguez-Lozano FJ. Cytotoxicity of Guttaflow Bioseal, Guttaflow 2, MTA Fillapex, and AH Plus on human periodontal ligament stem cells. J Endod 2017;43:816-822. ArticlePubMed
- 15. Pinheiro LS, Iglesias JE, Boijink D, Mestieri LB, Poli Kopper PM, Figueiredo JA, Grecca FS. Cell viability and tissue reaction of NeoMTA Plus: an in vitro and in vivo study. J Endod 2018;44:1140-1145. PubMed
- 16. Almeida LH, Gomes AP, Gastmann AH, Pola NM, Moraes RR, Morgental RD, Cava SS, Felix AO, Pappen FG. Bone tissue response to an MTA-based endodontic sealer, and the effect of the addition of calcium aluminate and silver particles. Int Endod J 2019;52:1446-1456. PubMed
- 17. Khan S, Kaleem M, Fareed MA, Habib A, Iqbal K, Aslam A, Ud Din S. Chemical and morphological characteristics of mineral trioxide aggregate and Portland cements. Dent Mater J 2016;35:112-117. ArticlePubMed
- 18. Zhou HM, Shen Y, Zheng W, Li L, Zheng YF, Haapasalo M. Physical properties of 5 root canal sealers. J Endod 2013;39:1281-1286. ArticlePubMed
- 19. Camps J, About I. Cytotoxicity testing of endodontic sealers: a new method. J Endod 2003;29:583-586. ArticlePubMed
- 20. Tanomaru-Filho M, Andrade AS, Rodrigues EM, Viola KS, Faria G, Camilleri J, Guerreiro-Tanomaru JM. Biocompatibility and mineralized nodule formation of Neo MTA Plus and an experimental tricalcium silicate cement containing tantalum oxide. Int Endod J 2017;50(Supplement 2):e31-e39. PubMed
- 21. Borges RP, Sousa-Neto MD, Versiani MA, Rached-Júnior FA, De-Deus G, Miranda CE, Pécora JD. Changes in the surface of four calcium silicate-containing endodontic materials and an epoxy resin-based sealer after a solubility test. Int Endod J 2012;45:419-428. ArticlePubMed
- 22. Mahdi JG, Alkarrawi MA, Mahdi AJ, Bowen ID, Humam D. Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells. Cell Prolif 2006;39:249-260. ArticlePubMedPMC
- 23. Silva Almeida LH, Moraes RR, Morgental RD, Pappen FG. Are premixed calcium silicate-based endodontic sealers comparable to conventional materials? A systematic review of in vitro studies. J Endod 2017;43:527-535. ArticlePubMed
- 24. ISO-Standards ISO 10993 Biological evaluation of medical devices - part 5: tests for in vitro cytotoxicity. Geneva: International Organization for Standardization; 2009.
REFERENCES
Tables & Figures
REFERENCES
Citations
Citations to this article as recorded by 
ePub Link
Cite
XML DownloadCytocompatibility and cell proliferation evaluation of calcium phosphate-based root canal sealers
Figure 1 Cell viability results (%) by 3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide (MTT) assay in 3T3 cells exposed to 24 hours for AH Plus, MTA Fillapex and BC Sealer, at dilution of 1:1, 1:2 and 1:4, according to the control group (100% viability rate). Bars with different letters represent significant differences among groups in each dilution extract (p < 0.05).
Figure 2 Cell migration results by scratch assay in 3T3 cells exposed to set extracts of AH Plus, MTA Fillapex and BC Sealer at dilution of 1:8. Percentage of open area by scratch assay in 3T3 cells. Columns with different letters represent significant differences between groups in each evaluated period.
Figure 3 Illustrative image of scratch assay in 3T3 cells.
Figure 1
Figure 2
Figure 3
Cytocompatibility and cell proliferation evaluation of calcium phosphate-based root canal sealers
